Stay updated on Nivolumab in Refractory Biliary Tract Cancers Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The government funding status notice at the top of the page was removed. No study details, eligibility criteria, or results were changed.
    Difference
    0.4%
    Check dated 2025-11-18T07:21:51.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The page now displays branding for the Moffitt Cancer Center and Research Institute and includes a Helpful Links section.
    Difference
    0.2%
    Check dated 2025-11-11T03:02:02.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The page shows updated study record dates, including the last update and results posting dates. Core study details such as completion status and locations appear current.
    Difference
    0.4%
    Check dated 2025-11-03T21:24:44.000Z thumbnail image
  4. Check
    44 days ago
    Change Detected
    Summary
    - Added a government funding lapse notice and operating status details for the NIH Clinical Center, plus a link to relevant official sites. - Upgraded version from v3.1.0 to v3.2.0.
    Difference
    3%
    Check dated 2025-10-06T05:59:49.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    The page updates its metadata to reflect a newer version (v3.1.0) and more recent dates (September 2025), while removing older metadata (v3.0.2 and May 2025 dates).
    Difference
    0.7%
    Check dated 2025-09-29T03:14:39.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2; the 'Back to Top' control was removed. No substantive changes to core content, pricing, names, stock, or time slot availability.
    Difference
    0.2%
    Check dated 2025-09-14T20:12:54.000Z thumbnail image

Stay in the know with updates to Nivolumab in Refractory Biliary Tract Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page.